Company presentations
Light Chain Bioscience - Novimmune SA
Light Chain Bioscience is a company developing bispecific antibodies with a pipeline focused in immuno-oncology.
We leverage our native human bispecific antibody discovery platform to support both internal programs and our partnered projects in a wide variety of therapeutic indications.
Category
Clinical stage development company
Title of the presentation
Native Bispecific Antibodies for Immuno-oncology and Beyond
Speaker information
| Name | Position | Institution |
|---|---|---|
| Nicolas Fischer | CEO | Light Chain Bioscience - Novimmune SA |
